Latest News

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Key Insights Significant control over Nightingale Health Oyj by retail investors implies that the general public has...

As the Middle East navigates a period of market volatility driven by fluctuating oil prices and geopolitical tensions, small-cap stocks in the region present unique opportunities for investors seeking growth potential amid broader market challenges. In this context, identifying promising stocks like Mohammed Hadi Al-Rasheed and other emerging small caps requires a keen eye on fundamentals that can withstand external pressures while capitalizing on regional economic developments.

Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...

Fortum Oyj ( HEL:FORTUM ) has announced that on 14th of April, it will be paying a dividend of€0.74, which a reduction...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...

The Middle Eastern stock markets have recently faced downward pressure, primarily due to declining oil prices and geopolitical tensions, with Saudi Arabia's benchmark index leading the decline. In this environment of heightened caution and fluctuating commodity prices, dividend stocks can offer a measure of stability and income potential for investors seeking reliable returns amidst broader market volatility.

eQ Oyj's ( HEL:EQV1V ) dividend is being reduced from last year's payment covering the same period to €0.26 on the 2nd...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Fesh Fash Snack Food Production Company's ( TADAWUL:9515 ) price-to-earnings (or "P/E") ratio of 26.6x might make it...

Toyota Tsusho Corporation ( TSE:8015 ) has announced that it will pay a dividend of ¥58.00 per share on the 23rd of...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

With a price-to-earnings (or "P/E") ratio of 34.1x ICICI Lombard General Insurance Company Limited ( NSE:ICICIGI ) may...

With a price-to-earnings (or "P/E") ratio of 33.4x ECI Technology Holdings Limited ( HKG:8013 ) may be sending very...

Agilent Technologies (A) is putting automation, imaging, and AI tools front and center at the SLAS2026 conference in Boston, previewing new platforms aimed at workflow efficiency and regulatory compliance in pharma and biotech labs. See our latest analysis for Agilent Technologies. Despite the automation and AI product momentum, Agilent’s recent trading has been weaker, with a 30 day share price return of a 12.17% decline and a 1 year total shareholder return of an 11.48% decline, pointing to...

Recent share performance context Teradata (TDC) has drawn attention after a period of weaker share performance, with the stock down over the past month and past 3 months. This has prompted investors to reassess expectations and current valuation. See our latest analysis for Teradata. At a share price of US$26.75, Teradata’s recent momentum has been weak, with a 30 day share price return of a 13.96% decline and a 1 year total shareholder return of a 13.15% decline, pointing to fading...

YETI Holdings (YETI) is back in focus as investors look ahead to its upcoming full year results, weighing the company’s exit from manufacturing in China and its push into soft coolers and bags. See our latest analysis for YETI Holdings. YETI’s share price has had a mixed year, with a recent 27.01% 90 day share price return contrasted against a 35.80% decline over five years on a total shareholder return basis. This suggests near term momentum but a weaker long run track record. If YETI’s...

International Business Machines (IBM) is back in focus after reporting Q4 results with higher revenue and net income year over year, along with a new role supporting the U.S. Missile Defense Agency’s SHIELD program. See our latest analysis for International Business Machines. IBM’s share price has pulled back recently, with a 7 day share price return of 6.26% and a 30 day share price return of 4.16%. At the same time, the 1 year total shareholder return sits at 17.34% and the 5 year total...

If you are wondering whether LCI Industries is fairly priced or offering value right now, you are not alone. This article will walk through the key numbers that matter. The stock last closed at US$152.75, with returns of 2.3% over 7 days, 20.8% over 30 days, 22.9% year to date, 57.8% over 1 year, 49.1% over 3 years and 26.7% over 5 years. This naturally raises questions about what is already reflected in the current price. Recent coverage of LCI Industries has focused on how investors are...

Sato Shoji (TSE:8065) has released its Q3 2026 numbers, reporting total revenue of ¥74.2b and basic EPS of ¥72.24, alongside net income of ¥1,506m that keeps earnings in positive territory. The company has seen quarterly revenue range from ¥69.7b in Q4 2025 to ¥74.2b in Q3 2026. Over the same period, basic EPS has moved between ¥53.66 and ¥82.17, giving a view of how the top line and EPS have tracked together over the past six quarters. With a trailing net profit margin that has eased from...

BorgWarner (NYSE:BWA) declared a quarterly cash dividend, reaffirming its regular payout to shareholders. The board approval signals continued capital return through ongoing dividend distributions. BorgWarner focuses on powertrain and eMobility solutions for global automakers, with products that span combustion, hybrid, and electric vehicle technologies. For investors watching the auto components space, dividend decisions can be especially relevant as manufacturers and suppliers adjust...

Sangoma Technologies (TSX:STC) has released its Q2 2026 results, reporting revenue of US$51.45 million, basic EPS of a US$0.06 loss, and net income excluding extra items showing a loss of US$1.996 million. The company’s quarterly revenue moved from US$60.15 million in Q1 2025 to US$51.45 million in Q2 2026, while basic EPS was a US$0.06 loss in both Q1 2025 and this quarter. On a trailing twelve month basis, EPS stands at a US$0.17 loss on US$219.70 million of revenue and a net loss of...

Amphastar Pharmaceuticals recently reported that rising day-to-day expenses have outpaced revenue, causing its adjusted operating margin to contract by 4.3 percentage points. This margin pressure is particularly important for Amphastar, which operates with a relatively small revenue base and fewer distribution channels than larger drugmakers. We’ll examine how this adjusted operating margin compression shapes Amphastar’s investment narrative, particularly around cost control and operational...